Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Lenvima/Keytruda Added to TACE Extend PFS in HCC
September 18, 2024
- Kissei’s Fibroid Drug Linzagolix Hits German Market
September 18, 2024
- GSK’s Multiple Myeloma Drug Blenrep Filed in Japan
September 18, 2024
- Sandoz Now Distributor of FKB’s Humira Biosimilar in Japan
September 18, 2024
- MSD Files Belzutifan for von Hippel-Lindau Disease in Japan
September 18, 2024
- Japan’s 1st Tick-Borne Encephalitis Vaccine Now Available: Pfizer
September 17, 2024
- Taisho Seeks Japan Nod for Insomnia Med Vornorexant
September 13, 2024
- Opdivo-Yervoy Filed for 1st Line Use in MSI-H Colorectal Cancer in Japan
September 13, 2024
- Eisai Set on Streamlining Operations to Drive Drug Innovation: COO
September 13, 2024
- IBM, Kobe Biomedical Cluster Join Hands to Expedite Clinical Trials with AI
September 12, 2024
- Oral COVID Drugs Prescribed to 180,000 Patients: August Data
September 12, 2024
- ViiV’s Vocabria-Rekambys Combo Nets 50% Growth: Japan President
September 11, 2024
- Axcelead DDP, Acadia to Join Forces in Drug Discovery
September 11, 2024
- KM Biologics Bags Option to Osivax’s Universal Flu Vaccines
September 11, 2024
- Kissei, Reborna Form Research Tie-Up for Genetic Rare Diseases
September 10, 2024
- Healios, FDA Agree on Pivotal PIII Design for Cell Therapy MultiStem
September 10, 2024
- New Biomarker Analysis Data Out for Daiichi Sankyo’s TROP2 ADC
September 10, 2024
- Takeda Sheds Working Time by 110,000 Hours via Manufacturing DX
September 9, 2024
- Mitsubishi Chemical Denies Media Report on Pharma Divestiture
September 9, 2024
- Vabysmo Filed for Label Expansion into Angioid Streaks in Japan: Chugai
September 9, 2024
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…